Key points are not available for this paper at this time.
This sytematic review examines US Food and Drug Administration (FDA) premarket clearances for artificial intelligence and machine learning devices in radiology with emphasis on testing.
Sivakumar et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: